AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mayuglim M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Mayu Health Care

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Mayuglim M 1mg/500mg Tablet

Diabetac Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication assists in regulating blood glucose levels. Diabetac Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. It's a component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor; lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are crucial preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.

Uses of Mayuglim M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Mayuglim M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Mayuglim M 1mg/500mg tablets should be administered with a meal.

Common Side effects of Mayuglim M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Mayuglim M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Mayuglim M 1mg/500mg Tablet with a meal.

How Mayuglim M 1mg/500mg Tablet works:

Mayuglim M 1mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Mayuglim M 1mg/500mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Mayuglim M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Mayuglim M 1mg/500mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Mayuglim M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Mayuglim M 1mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Mayuglim M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. In those with mild to moderate hepatic dysfunction, initiation should be at a reduced dose; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Mayuglim M 1mg/500mg Tablet :

Should you forget to take a Mayuglim M 1mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mayuglim M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Mayuglim M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Mayuglim M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Mayuglim M 1mg/500mg Tablets and seek immediate medical attention.
Mayuglim M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Mayuglim M is not suitable for type 1 diabetes.
Mayuglim M 1mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Mayuglim M 1mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Mayuglim M 1mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Mayuglim M 1mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Mayuglim M 1mg/500mg Tabl...
62
MRP 76
18% off